Jessica Donington to Biomarkers, Tumor
This is a "connection" page, showing publications Jessica Donington has written about Biomarkers, Tumor.
Connection Strength
0.808
-
Invited commentary. Ann Thorac Surg. 2012 Feb; 93(2):403-4.
Score: 0.235
-
Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population. Cancer Biomark. 2012; 12(4):177-84.
Score: 0.234
-
Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer. J Thorac Oncol. 2010 Oct; 5(10):1516-23.
Score: 0.214
-
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
Score: 0.115
-
An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res. 2006 Mar 01; 12(5):1507-14.
Score: 0.010